© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions
Posted 18th February 2020

Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions

Top Blood and Marrow Transplant and Immunotherapy programs depend on Title21 Health Solution’s (Title21) technology to manage the patient, product and process data from collection to infusion. We had a chance to catch up with Lynn Fischer, the CEO at Title21 who provided us with a detailed insight into the award-winning software provider.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions
Title21

Top Blood and Marrow Transplant and Immunotherapy programs depend on Title21 Health Solution’s (Title21) technology to manage the patient, product and process data from collection to infusion. From reporting to analytics, Title21 provides all the critical data at your fingertips so the right person has the right data at the right time to make the right decisions. This allows Medical Technologists, Technical and Medical Directors to focus on higher-value work, and ultimately the patient, rather than chasing down paperwork and people.

Earlier this year, Title21 was selected as the Most Outstanding Cell Therapy Software Provider for 2019 by AI’s Global Excellence Award. We had a chance to catch up with Lynn Fischer, the CEO at Title21 who provided us with a detailed insight into the award-winning software provider.

Since their inception, Tile21’s Cloud and onpremise software manages critical patient, product and process data for cell and gene therapy, immunotherapy and regenerative medicine to ensure quality, compliance and traceability. Programs that implement Title21 solutions find they can scale more effectively to treat more patients and can also translate products more quickly and efficiently from bench to bedside, delivering the latest innovative therapies to patients faster and more safely.

Title21 has served FDA-regulated life science companies for many years with quality management software, so Title21’s experience has been of great service to the cell therapy segment. “Our technology is extremely flexible due to its configurability on the front end. That means that we can maintain a single code base while meeting each cancer center or cell manufacturers’ specific requirements.”

“Every team member at Title21 is dedicated to supporting the lifesaving work that health care providers do each and every day.”

“At Title21, we partner with the largest and top-rated cancer hospitals – placing the patient first. One of our greatest testimonials we hear often is that our customers want us to continue to solve more of their challenges with our technology. They ask Title21 to help provide solutions through technology to increase the quality, safety and efficiency of their programs.” Current Title21 customers have a strong influence on the technology roadmap to add value to patient therapeutic care and quality. Analytics and business intelligence are also important and play a significant role in the future of developing new cures and protocols more quickly and efficiently. Cell and gene therapy is a dynamic market and the protocols are changing rapidly as they are improved and refined.

Moving forward, the future looks bright for the team at Title21 as they continue to provide exceptional services and award-winning solutions to hospitals and biotech firms. “Our passion is to serve the many patients and their families who face life-threatening diseases by supporting the leading healthcare institutions and biotech companies with powerful tools that help them deliver innovative treatments to their patients. Every team member at Title21 is dedicated to supporting the lifesaving work that health care providers do each and every day” remarks Fischer.

Bringing the interview to a close, Lynn signs off by revealing the exciting plans which lie in the pipeline for the business, which includes their ambitions to further expand the business in the years to come, especially with the advancements in immunotherapy technology.

Categories: Innovation


You Might Also Like
Read Full PostRead - Eye Icon
Be Direct and Know Your Worth
Finance
26/06/2017Be Direct and Know Your Worth

Atomic Weapons Establishment (AWE) plays a crucial role in the UK’s national defence. They have been at the forefront of the UK nuclear deterrence programme for more than 60 years. Supporting the UK’s Continuous at Sea Deterrence programme and national nuc

Read Full PostRead - Eye Icon
Serry Law Office
Legal
22/05/2015Serry Law Office

Serry Law Office was established in 1937 and has been offering corporate and real estate legal services in the Arab Republic of Egypt for many of the leading national and multinational companies.

Read Full PostRead - Eye Icon
Extended-Stay Software for Hospitality Innovation
Innovation
11/02/2026Extended-Stay Software for Hospitality Innovation

Gearco, Inc. is a cloud management solutions provider like no other. With its drive to empower extended-stay properties through state-of-the-art technology being stronger now than ever before.

Read Full PostRead - Eye Icon
Jet Environmental and Jet AHU Acquired by Wozair Ltd
M&A
14/07/2016Jet Environmental and Jet AHU Acquired by Wozair Ltd

Jet Environmental Systems Ltd, the provider of temperature control solutions for industrial and commercial buildings, and its sister company Jet AHU Ltd, which supplies and installs air handling units, have been acquired by Wozair Ltd.

Read Full PostRead - Eye Icon
Comprehensive Guide to Understanding Your Benefit Entitlements
News
27/10/2023Comprehensive Guide to Understanding Your Benefit Entitlements

If you’re on the journey of hiring in the beautiful land of Australia, it’s super crucial to nail that benefits package. Not only do you need to stay aligned with Australia’s labour laws (no one likes legal hiccups, right?), but you also want

Read Full PostRead - Eye Icon
5 Innovative Ways to Celebrate Milestones in Modern Businesses
News
09/05/20245 Innovative Ways to Celebrate Milestones in Modern Businesses

In the ever-evolving landscape of modern businesses, celebrating milestones has taken on new dimensions. It’s about recognizing achievements and creating moments that inspire teams. With creativity at the helm, companies are now exploring innovative ways

Read Full PostRead - Eye Icon
5 Options for Funding Your Small Business – Whatever Stage You’re At
Finance
11/10/20225 Options for Funding Your Small Business – Whatever Stage You’re At

No matter the stage you are at with your business, you might be heading for success and growth. However, for you to achieve your goals and beat the competition ahead, you need to have funds to ensure that your business meets its needs.

Read Full PostRead - Eye Icon
Tangiers Group Acquires Osprey
Finance
08/04/2015Tangiers Group Acquires Osprey

Tangiers Group Acquires Osprey

Read Full PostRead - Eye Icon
Banks Among the Worst at Blaming Customers When Things Go Wrong
Finance
26/05/2015Banks Among the Worst at Blaming Customers When Things Go Wrong

The traditional mantra for successful businesses ‘the customer is always right’ is under threat according to new research by alldayPA.



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow